Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124729163 | 12472916 | 3 | F | 2009 | 20160628 | 20160616 | 20160705 | EXP | DE-GILEAD-2016-0217936 | GILEAD | 51.00 | YR | A | M | Y | 0.00000 | 20160705 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124729163 | 12472916 | 1 | PS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 1 DF, UNK | N | 21356 | 1 | DF | TABLET | ||||||
| 124729163 | 12472916 | 2 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 1 DF, QOD | N | 21356 | 1 | DF | TABLET | QOD | |||||
| 124729163 | 12472916 | 3 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 1 DF, Q3WK | N | 21356 | 1 | DF | TABLET | Q3W | |||||
| 124729163 | 12472916 | 4 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 1 DF, Q3WK | N | 21356 | 1 | DF | TABLET | Q3W | |||||
| 124729163 | 12472916 | 5 | C | ATAZANAVIR SULFATE W/RITONAVIR | ATAZANAVIR SULFATERITONAVIR | 1 | Unknown | UNK | 0 | ||||||||||
| 124729163 | 12472916 | 6 | C | KIVEXA | ABACAVIR SULFATELAMIVUDINE | 1 | 0 | ||||||||||||
| 124729163 | 12472916 | 7 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | UNK | 0 | ||||||||||
| 124729163 | 12472916 | 8 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Unknown | UNK | 0 | ||||||||||
| 124729163 | 12472916 | 9 | C | PAROXETIN /00830801/ | PAROXETINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 124729163 | 12472916 | 10 | C | PENICILLIN /00000901/ | PENICILLIN G | 1 | Unknown | UNK | 0 | ||||||||||
| 124729163 | 12472916 | 11 | C | LYRICA | PREGABALIN | 1 | Unknown | UNK | 0 | ||||||||||
| 124729163 | 12472916 | 12 | C | QUETIAPIN | QUETIAPINE | 1 | Unknown | UNK | 0 | ||||||||||
| 124729163 | 12472916 | 13 | C | ASA | ASPIRIN | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124729163 | 12472916 | 1 | Chronic hepatitis B |
| 124729163 | 12472916 | 5 | HIV infection |
| 124729163 | 12472916 | 6 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124729163 | 12472916 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124729163 | 12472916 | Blood creatinine increased | |
| 124729163 | 12472916 | Chronic kidney disease | |
| 124729163 | 12472916 | Fanconi syndrome acquired | |
| 124729163 | 12472916 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124729163 | 12472916 | 1 | 200705 | 201602 | 0 | |
| 124729163 | 12472916 | 2 | 2009 | 0 | ||
| 124729163 | 12472916 | 3 | 201102 | 201404 | 0 | |
| 124729163 | 12472916 | 4 | 201412 | 201602 | 0 |